Back to Search
Start Over
Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn’s Disease.
- Source :
- American Journal of Gastroenterology (Lippincott Williams & Wilkins); Apr2023, Vol. 118 Issue 4, p674-684, 11p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 00029270
- Volume :
- 118
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- American Journal of Gastroenterology (Lippincott Williams & Wilkins)
- Publication Type :
- Academic Journal
- Accession number :
- 162922951
- Full Text :
- https://doi.org/10.14309/ajg.0000000000002068